Literature DB >> 12519072

Effects of prenatal glucocorticoid exposure on cardiac calreticulin and calsequestrin protein expression during early development and in adulthood.

Maria L Langdown1, Mark J Holness, Mary C Sugden.   

Abstract

Overexpression of the conserved Ca(2+)-binding proteins calreticulin and calsequestrin impairs cardiac function, leading to premature death. Calreticulin is vital for embryonic development, but also impairs glucocorticoid action. Glucocorticoid overexposure during late fetal life causes intra-uterine growth retardation and programmed hypertension in adulthood. To determine whether intra-uterine growth retardation or programmed hypertension was associated with altered calreticulin or calsequestrin expression, effects of prenatal glucocorticoid overexposure (maternal dexamethasone treatment on days 15-21 of pregnancy) were examined during fetal life and postnatal development until adulthood (24 weeks). Dexamethasone (100 or 200 microg/kg of maternal body weight) was administered via osmotic pump. Calreticulin was detected as a 55 kDa band and calsequestrin as 55 and 63 kDa bands in 21 day fetal hearts. Only the 55 kDa calsequestrin band was detected postnatally. Prenatal glucocorticoid overexposure at the higher dose decreased calreticulin protein expression (26%; P <0.05) but increased calsequestrin protein expression, both 55 and 63 kDa bands, by 87% ( P <0.01) and 78% ( P <0.01); only the 55 kDa calsequestrin band was increased at the lower dose (66%; P <0.05). Offspring of dams treated at the lower dexamethasone dose were studied further. In control offspring, cardiac calreticulin protein expression declined between 2 and 3 weeks of age, and remained suppressed until adulthood. Cardiac calsequestrin protein expression increased 2-fold between fetal day 21 and postnatal day 1 and continued to increase until adulthood, at which time it was 3.4-fold higher ( P <0.001). Prenatal dexamethasone exposure minimally affected postnatal calsequestrin protein expression, but the postnatal decline in calreticulin protein expression was abrogated and calreticulin protein expression in adulthood was 2.2-fold increased ( P <0.001) compared with adult controls. In view of the known associations between cardiac calreticulin overexpression and impaired cardiac function, targeted up-regulation of calreticulin may contribute to the increased risk of adult heart disease introduced as a result of prenatal overexposure to glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519072      PMCID: PMC1223268          DOI: 10.1042/BJ20021771

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

Review 1.  In utero programming of cardiovascular disease.

Authors:  D J Barker
Journal:  Theriogenology       Date:  2000-01-15       Impact factor: 2.740

2.  Heart, brain, and body wall defects in mice lacking calreticulin.

Authors:  F Rauch; J Prud'homme; A Arabian; S Dedhar; R St-Arnaud
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

Review 3.  Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of Type 2 diabetes mellitus.

Authors:  M J Holness; M L Langdown; M C Sugden
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

4.  Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding.

Authors:  M J Holness; A Kraus; R A Harris; M C Sugden
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

5.  Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.

Authors:  M C Sugden; K Bulmer; D Augustine; M J Holness
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

6.  Complete heart block and sudden death in mice overexpressing calreticulin.

Authors:  K Nakamura; M Robertson; G Liu; P Dickie; K Nakamura; J Q Guo; H J Duff; M Opas; K Kavanagh; M Michalak
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

7.  Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression.

Authors:  M C Cho; A Rapacciuolo; W J Koch; Y Kobayashi; L R Jones; H A Rockman
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

8.  Early growth retardation induced by excessive exposure to glucocorticoids in utero selectively increases cardiac GLUT1 protein expression and Akt/protein kinase B activity in adulthood.

Authors:  M L Langdown; M J Holness; M C Sugden
Journal:  J Endocrinol       Date:  2001-04       Impact factor: 4.286

Review 9.  Calreticulin: one protein, one gene, many functions.

Authors:  M Michalak; E F Corbett; N Mesaeli; K Nakamura; M Opas
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

10.  Calreticulin Is a receptor for nuclear export.

Authors:  J M Holaska; B E Black; D C Love; J A Hanover; J Leszyk; B M Paschal
Journal:  J Cell Biol       Date:  2001-01-08       Impact factor: 10.539

View more
  3 in total

1.  The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2).

Authors:  Guy Katz; Asher Shainberg; Edith Hochhauser; Efrat Kurtzwald-Josefson; Ahuva Issac; Dalia El-Ani; Dan Aravot; Arnon Afek; Jonathan G Seidman; Christine E Seidman; Michael Eldar; Michael Arad
Journal:  Biochem Pharmacol       Date:  2013-09-23       Impact factor: 5.858

Review 2.  Glucocorticoids and programming of the microenvironment in heart.

Authors:  Rui Song; Xiang-Qun Hu; Lubo Zhang
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

3.  Increased activation of stromal interaction molecule-1/Orai-1 in aorta from hypertensive rats: a novel insight into vascular dysfunction.

Authors:  Fernanda R C Giachini; Chin-Wei Chiao; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Anne M Dorrance; Rita C Tostes; R Clinton Webb
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.